Cargando…
Hopes and Hurdles of Employing Mesenchymal Stromal Cells in the Treatment of Cardiac Fibrosis
Excessive cardiac fibrosis plays a crucial role in almost all types of heart disease. Generally, cardiac fibrosis is a scarring process triggered in response to stress, injury, or aging and is characterized by the accumulation of activated myofibroblasts that deposit high levels of extracellular mat...
Autores principales: | Neuber, Sebastian, Emmert, Maximilian Y., Nazari-Shafti, Timo Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657815/ https://www.ncbi.nlm.nih.gov/pubmed/34884805 http://dx.doi.org/10.3390/ijms222313000 |
Ejemplares similares
-
Treatment of Cardiac Fibrosis with Extracellular Vesicles: What Is Missing for Clinical Translation?
por: Neuber, Sebastian, et al.
Publicado: (2023) -
Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular disease
por: Nazari‐Shafti, Timo Z., et al.
Publicado: (2020) -
MiRNA Profiles of Extracellular Vesicles Secreted by Mesenchymal Stromal Cells—Can They Predict Potential Off-Target Effects?
por: Nazari-Shafti, Timo Z., et al.
Publicado: (2020) -
The path to a hemocompatible cardiovascular implant: Advances and challenges of current endothelialization strategies
por: Exarchos, Vasileios, et al.
Publicado: (2022) -
Immunotherapy in prostate cancer: new horizon of hurdles and hopes
por: Tsaur, Igor, et al.
Publicado: (2020)